Wyeth Korea to extend Enbrel's NHI coverage term.

Published: 2006-05-09 06:59:00

Updated: 2006-05-09 06:59:00

Wyeth Korea said that the NHI reimbursement period of Enbrel inj. would be remarkably extended for the treatment of ankylosing spondylitis taking effect from May this year according to the revised NHI payment standards.

So far the NHI coverage for Enbrel treatment was limited for 9 months bu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK